Advocacy at a Glance STEVEN GROSSMAN 6/8/18 Advocacy at a Glance STEVEN GROSSMAN 6/8/18 FDA Funding Likely to Reach House, then Senate Floor as Part of a Mini-bus Read More Analysis and Commentary STEVEN GROSSMAN 6/1/18 Analysis and Commentary STEVEN GROSSMAN 6/1/18 Strong BA Support for FDA on Capitol Hill -- At Different Levels Read More Advocacy at a Glance STEVEN GROSSMAN 6/1/18 Advocacy at a Glance STEVEN GROSSMAN 6/1/18 FDA Appropriations Likely to Move Early Read More Analysis and Commentary STEVEN GROSSMAN 5/24/18 Analysis and Commentary STEVEN GROSSMAN 5/24/18 FY 19 Funding: House and Senate Proposals Read More Advocacy at a Glance STEVEN GROSSMAN 5/25/18 Advocacy at a Glance STEVEN GROSSMAN 5/25/18 Senate Appropriators Move FY 19 Ag/FDA Bill Forward and more Read More Analysis and Commentary STEVEN GROSSMAN 5/17/18 Analysis and Commentary STEVEN GROSSMAN 5/17/18 House Recommends Major Increase in BA Funding Read More Advocacy at a Glance STEVEN GROSSMAN 5/18/18 Advocacy at a Glance STEVEN GROSSMAN 5/18/18 House Appropriations Committee Passes Ag/FDA Bill With $308 Million Increase and more Read More Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More Advocacy at a Glance STEVEN GROSSMAN 5/11/18 Advocacy at a Glance STEVEN GROSSMAN 5/11/18 House Appropriations Bill Provides FDA with a $300+ Million Increase and more Read More STEVEN GROSSMAN 5/10/18 STEVEN GROSSMAN 5/10/18 Alliance "Deeply Appreciative" of House's FY 19 Funding Mark Read More Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More Analysis and Commentary STEVEN GROSSMAN 4/27/18 Analysis and Commentary STEVEN GROSSMAN 4/27/18 FY 19 -- Off to a Great Start Read More Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Alliance’s Advocacy Day a Success! Read More Analysis and Commentary STEVEN GROSSMAN 4/21/18 Analysis and Commentary STEVEN GROSSMAN 4/21/18 The Alliance's "Ask" for FY 19 Read More Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Alliance’s Hill Day on April 25. Please Join Us Read More Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Notes from the Alliance’s Meeting with CBER Director Peter Marks and more Read More Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Support FDA By Participating In the Alliance’s Hill Day on April 25 Read More Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 6/8/18 Advocacy at a Glance STEVEN GROSSMAN 6/8/18 FDA Funding Likely to Reach House, then Senate Floor as Part of a Mini-bus Read More
Analysis and Commentary STEVEN GROSSMAN 6/1/18 Analysis and Commentary STEVEN GROSSMAN 6/1/18 Strong BA Support for FDA on Capitol Hill -- At Different Levels Read More
Advocacy at a Glance STEVEN GROSSMAN 6/1/18 Advocacy at a Glance STEVEN GROSSMAN 6/1/18 FDA Appropriations Likely to Move Early Read More
Analysis and Commentary STEVEN GROSSMAN 5/24/18 Analysis and Commentary STEVEN GROSSMAN 5/24/18 FY 19 Funding: House and Senate Proposals Read More
Advocacy at a Glance STEVEN GROSSMAN 5/25/18 Advocacy at a Glance STEVEN GROSSMAN 5/25/18 Senate Appropriators Move FY 19 Ag/FDA Bill Forward and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/17/18 Analysis and Commentary STEVEN GROSSMAN 5/17/18 House Recommends Major Increase in BA Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 5/18/18 Advocacy at a Glance STEVEN GROSSMAN 5/18/18 House Appropriations Committee Passes Ag/FDA Bill With $308 Million Increase and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More
Advocacy at a Glance STEVEN GROSSMAN 5/11/18 Advocacy at a Glance STEVEN GROSSMAN 5/11/18 House Appropriations Bill Provides FDA with a $300+ Million Increase and more Read More
STEVEN GROSSMAN 5/10/18 STEVEN GROSSMAN 5/10/18 Alliance "Deeply Appreciative" of House's FY 19 Funding Mark Read More
Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More
Analysis and Commentary STEVEN GROSSMAN 4/27/18 Analysis and Commentary STEVEN GROSSMAN 4/27/18 FY 19 -- Off to a Great Start Read More
Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Advocacy at a Glance STEVEN GROSSMAN 4/27/18 Alliance’s Advocacy Day a Success! Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/18 Analysis and Commentary STEVEN GROSSMAN 4/21/18 The Alliance's "Ask" for FY 19 Read More
Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Alliance’s Hill Day on April 25. Please Join Us Read More
Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Advocacy at a Glance STEVEN GROSSMAN 4/13/18 Notes from the Alliance’s Meeting with CBER Director Peter Marks and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Support FDA By Participating In the Alliance’s Hill Day on April 25 Read More
Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More
